Samuel J Ivan, MD in Charlotte, NC - Medicare Urology

Samuel J Ivan, MD is a medicare enrolled "Urology" physician in Charlotte, North Carolina. His current practice location is 1000 Blythe Blvd, Charlotte, North Carolina. You can reach out to his office (for appointments etc.) via phone at (704) 446-9243.

Samuel J Ivan is licensed to practice in North Carolina (license number 250301) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1902366222.

Contact Information

	Samuel J Ivan, MD
	1000 Blythe Blvd, Charlotte, NC 28203-5812
	(704) 446-9243
	Not Available

Physician's Profile

Full Name	Samuel J Ivan
Gender	Male
Speciality	Urology
Location	1000 Blythe Blvd, Charlotte, North Carolina
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1902366222
Provider Enumeration Date: 03/22/2019
Last Update Date: 03/22/2019

Medicare PECOS Information:

PECOS PAC ID: 4880920131
Enrollment ID: I20190725000060

Medical Identifiers

Medical identifiers for Samuel J Ivan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1902366222	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	250301 (North Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Samuel J Ivan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Samuel J Ivan, MD 2222 Sherwood Ave Apt 32, Toledo, OH 43614-4363 Ph: (419) 708-3980	Samuel J Ivan, MD 1000 Blythe Blvd, Charlotte, NC 28203-5812 Ph: (704) 446-9243

News Archive

Scientists create detailed image of deadly toxin linked to bacterial pneumonia, meningitis, septicaemia

Scientists from the University of Leicester have for the first time created a detailed image of a toxin - called pneumolysin - associated with deadly infections such as bacterial pneumonia, meningitis and septicaemia.

International initiative seeks to reduce heterosexual HIV transmission

Los Angeles Biomedical Research Institute has received a $350,000 grant to study the safety of a gel designed to reduce the heterosexual transmission of HIV from the International Partnership for Microbicides, a nonprofit global initiative to develop products to reduce HIV transmission, and the U.S. Agency for International Development, the Institute announced today.

Australia's Mesoblast receives nod to start first European trial of allogeneic stem cell treatment for heart attacks

Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor™ is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).

European joint project to develop novel HCV vaccine based on nanotechnology

HCVAX is a European joint project that reaches out to develop a vaccine against hepatitis C based on nanotechnology. The German Helmholtz Centre for Infection Research in Braunschweig and its department "Vaccinology and Applied Microbiology" is now a part of the transnational consortium with researchers from Germany, France and Switzerland.

Degree of emphysema predicts mortality in ever-smokers with or without COPD

Severity of emphysema, as measured by computed tomography (CT), is a strong independent predictor of all-cause, cardiovascular, and respiratory mortality in ever-smokers with or without chronic obstructive pulmonary disease (COPD), according to a study from researchers in Norway. In patients with severe emphysema, airway wall thickness is also associated with mortality from respiratory causes.

Urology Doctors in Charlotte, NC

Mark J. Makhuli, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1225 Harding Pl, Ste 3100, Charlotte, NC 28204 Phone: 704-355-8686
Dr. George Albert Dasher, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 10512 Park Rd, Suite 113, Charlotte, NC 28210 Phone: 704-541-8207
Dr. Craig H Robson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 335 N Caswell Rd, Charlotte, NC 28204 Phone: 704-384-7980
Peter Earl Clark, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1021 Morehead Medical Dr, Ste 6100, Charlotte, NC 28204 Phone: 980-442-2000
Jonathan Pierce Walker, MD Urology Medicare: Medicare Enrolled Practice Location: 1001 Blythe Blvd, Charlotte, NC 28203 Phone: 704-446-5070
E Matthew Dilizia, MD Urology Medicare: Medicare Enrolled Practice Location: 10660 Park Rd Ste 4100, Charlotte, NC 28210 Phone: 704-541-8207 Fax: 704-540-8288
Dr. Lawrence Andrew Eskew, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 335 N Caswell Rd, Charlotte, NC 28204 Phone: 704-384-7980 Fax: 704-384-7985

Samuel J Ivan, MD - Medicare Urology in Charlotte, NC